Quantcast
Last updated on April 20, 2014 at 5:20 EDT

Latest arthritis Stories

2014-01-10 23:22:13

Dr. Teresa Sievers, Florida Board Certified Internal Medicine, Fellow Anti-Aging, Regenerative & Functional Medicine professional, joins Cape Coral-based Flexcin International, Inc. in promoting the benefits of all–natural Flexcin with CM8®. Ft. Myers, Florida (PRWEB) January 10, 2014 Flexcin International, Inc., announces that Teresa Sievers M. D., Board Certified Internal Medicine, and Board Certified and Fellowship trained in Anti-aging Medicine, has become a spokesperson...

2014-01-08 08:28:48

PORTLAND, Ore., Jan. 8, 2014 /PRNewswire-USNewswire/ -- To advance understanding of psoriasis--the most common autoimmune disease in the country, affecting up to 7.5 million Americans--and help scientists and clinicians improve treatments and patient outcomes, the National Psoriasis Foundation (NPF) and the Consortium of Rheumatology Researchers of North America, Inc. (CORRONA) will create the first psoriasis registry co-developed and co-administered by a nonprofit. (Photo:...

2013-12-31 16:22:09

What is Lupus? WASHINGTON, Dec. 31, 2013 /PRNewswire-USNewswire/ -- There have been many reports and rumors in the media and on the internet, asking questions about the autoimmune disease lupus and who might be suffering from this devastating disease. (Photo: http://photos.prnewswire.com/prnh/20131231/DC39345-INFO) (Logo: http://photos.prnewswire.com/prnh/20121113/DC11393LOGO) The real question is: what is lupus? What are the debilitating effects of living with the disease? When...

2013-12-31 08:22:46

Following the Successful Utilization of A3 Adenosine Receptor Biomarker in Can-Fite's Phase IIb Rheumatoid Arthritis Study PETACH TIKVA, Israel, Dec. 31, 2013 /PRNewswire/ -- Can-Fite BioPharma Ltd. (TASE: CFBI), (NYSE MKT: CANF), a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, announced today the following: The Company's subsidiary, OphthaliX Inc. (OTCQB: OPLI), will conduct a retrospective analysis...

2013-12-31 08:22:44

PETACH TIKVA, Israel, Dec. 31, 2013 /PRNewswire/ -- OphthaliX Inc. (OTCQB: OPLI), announced today that it will conduct a retrospective analysis of the Phase III Dry Eye Syndrome study data to determine if there is a correlation between the CF101 target, the A3 adenosine receptor, expression and patients' response to the drug. This analysis is based on recent positive data from a Phase IIb Rheumatoid Arthritis study of CF101 conducted by OphthaliX's parent company, Can-Fite BioPharma...

2013-12-30 23:24:25

All Natural, USA-made FlexEquine’s new site showcases a user-friendly format for customers. Fort Myers, Florida (PRWEB) December 30, 2013 Flexcin International, Inc., the makers of all-natural health products for adults and pets announces it latest product, FlexEquine, for horses. FlexEquine utilizes the same human-grade ingredients found in the adult version Flexcin. The primary component, Cetyl Myristoleate (CM8®), works to lubricate the joints and muscles and reduce inflammation...

2013-12-30 23:24:22

Flexcin International, Inc. makers of USA made all natural health products creates new site for flagship brand, Flexcin with CM8®. Ft. Myers, Florida (PRWEB) December 30, 2013 - Flexcin International, Inc., the makers of all-natural health products including Flexcin with CM8®,a joint nutritional product that helps to alleviate the pain and stiffness associated with diseases like Arthritis and Fibromyalgia, launched a new website for Flexcin. The new website...

2013-12-30 00:20:21

PETACH TIKVA, Israel, Dec. 30, 2013 /PRNewswire/ -- Can-Fite BioPharma Ltd. (TASE:CFBI), (NYSE MKT:CANF), a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, announced today that its subsidiary OphthaliX Inc. (OTCBB:OPLI) released results from a 24 week, placebo-controlled phase III study involving 237 patients with moderate-to-severe Dry Eye Syndrome who were treated with its licensed drug CF101, an A3 adenosine...

2013-12-27 23:00:09

Psoriasis Essentials designed by Jenelle Jordyn is the latest program that provides people with safe and natural remedies for their psoriasis vulgaris. Is Psoriasis Essentials review trustworthy? Seattle, Wa (PRWEB) December 27, 2013 Psoriasis is a common skin disease, which affects the life cycle of skin cells. This disease is characterized by scaly and reddened (erythematous) patches, papules, and plaques that are usually itchy (pruritic). Psoriasis Essentials is a new solution for...

2013-12-26 23:02:27

With Synflex, Maker of Liquid Glucosamine Supplement Designed for Those Who Suffer From Arthritis Induced Pain and Discomfort, Excruciating Pain is a Thing of The Past Boca Raton, Fla. (PRWEB) December 26, 2013 Synflex America, Inc., the makers of liquid Glucosamine supplements designed for those suffering from osteoarthritis, family pets, and athletes is expanding its U.S. and Global operations. Syn-flex® is a powerful liquid Glucosamine and Chondroitin supplement formulated for...


Latest arthritis Reference Libraries

Weather Reference Library
2012-05-21 10:01:55

Can someone with arthritis forecast the weather? It is possible even though most people don’t think so. Anyone that has some form of arthritis can tell you when it’s about to get colder as there joints start to flare up and the pain starts to increase. This is because the temperature is getting colder and high pressure is moving into the area. When high pressure moves into an area it is made up of colder weather which is the cold air sinking from the upper levels of the atmosphere down...

More Articles (1 articles) »